ArticleTrials2025

RANK-ligand inhibition to combat sarcopenia with underlying osteoporosis: a study protocol for a randomized, double-blind, double-dummy, active-controlled trial.

Ronald Man Yeung Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.